(Q35776464)

10 August 2017

1 reference

title

Assisted reproduction in the treatment of polycystic ovarian syndrome (English)

1 reference

10 August 2017

Bulent Urman

1

1 reference

10 August 2017

Bulent Tiras

series ordinal

2

1 reference

10 August 2017

Kayhan Yakin

series ordinal

3

1 reference

10 August 2017

language of work or name

1 reference

1 April 2004

1 reference

Reproductive BioMedicine Online

10 August 2017

published in

1 reference

10 August 2017

volume

8

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

419-430

1 reference

Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Oocyte quality in patients with severe ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Does ovarian hyperstimulation syndrome affect the quality of oocytes?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

GnRH antagonist in assisted reproduction: a Cochrane review

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Meta-analysis of recombinant versus urinary-derived FSH: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Hypersecretion of luteinizing hormone and the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Production of embryos from in vitro-matured primary human oocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Insulin resistance in nonobese patients with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Ovarian hyperstimulation syndrome: strategies for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Pregnancies resulting from in vitro matured oocytes retrieved from patients with polycystic ovary syndrome after priming with human chorionic gonadotropin.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Maturation in vitro of human oocytes from unstimulated cycles: selection of the optimal day for ovum retrieval based on follicular size

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

In vitro fertilization following laparoscopic ovarian diathermy in patients with polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

"Coasting" (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

The relationship between size and maturation in vitro in the unstimulated human oocyte

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

'Early coasting' in patients with polycystic ovarian syndrome is consistent with good clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Oocyte-expressed TGF-beta superfamily members in female fertility

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Rescue IVF and coasting with the use of a GnRH antagonist after ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Impaired insulin action on granulosa-lutein cells in women with polycystic ovary syndrome and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Gonadotrophin regimens and oocyte quality in women with polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Follitropin-α versus human menopausal gonadotropin in an in vitro fertilization program

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Correctly timed coasting reduces the risk of ovarian hyperstimulation syndrome and gives good cycle outcome in an in vitro fertilization program

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Ovulation induction in perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Comparison of the effectiveness of recombinant and urinary FSH preparations in the achievement of follicular selection in chronic anovulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Prophylactic intravenous hydroxyethyle starch solution prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: a prospective, randomized, double-blind and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Coasting--what is the best formula?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

The link between female infertility and cancer: epidemiology and possible aetiologies

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

GnRH agonists as adjuncts for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Morphology of in-vitro matured oocytes: impact on fertility potential and embryo quality.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

In-vitro maturation of human oocytes from regularly menstruating women may be successful without follicle stimulating hormone priming.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

IVF outcome in anovulatory infertility (WHO group 2)--including polycystic ovary syndrome--following previous unsuccessful ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Coasting may reduce the severity of the ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Polycystic ovaries--a common finding in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Hypersecretion of luteinising hormone, infertility, and miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Impact of metformin therapy on ovarian stimulation and outcome in 'coasted' patients with polycystic ovary syndrome undergoing in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

In-vitro maturation of oocytes from unstimulated polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Does laparoscopic ovarian diathermy affect the outcome of IVF-embryo transfer in women with polycystic ovarian syndrome? A retrospective comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients*

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Maturation of human oocytes in vitro and their developmental competence.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome: a systematic review based on a Cochrane review

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by 'prolonged coasting' of very hyperstimulated patients: a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic,chronic anovulation: a prospective randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960926-1

7 January 2021

10.1016/S1472-6483(10)60926-1

Identifiers

DOI

1 reference

10 August 2017

1 reference